Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany

View ORCID ProfileSiegbert Rieg, Maja von Cube, Johannes Kalbhenn, Stefan Utzolino, Katharina Pernice, Lena Bechet, Johanna Baur, Corinna N. Lang, Dirk Wagner, Martin Wolkewitz, Winfried V. Kern, Paul Biever
doi: https://doi.org/10.1101/2020.07.22.20160127
Siegbert Rieg
1Division of Infectious Diseases, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Siegbert Rieg
  • For correspondence: siegbert.rieg@uniklinik-freiburg.de
Maja von Cube
2Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, 79104 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Kalbhenn
3Department of Anesthesiology and Intensive Care Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Utzolino
4Department of General and Visceral Surgery, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katharina Pernice
5Department of Cardiovascular Surgery, Heart Center, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lena Bechet
1Division of Infectious Diseases, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanna Baur
6Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
7Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corinna N. Lang
6Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
7Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk Wagner
1Division of Infectious Diseases, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Wolkewitz
2Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, 79104 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winfried V. Kern
1Division of Infectious Diseases, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Biever
6Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
7Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Reported mortality of hospitalised COVID-19 patients varies substantially, particularly in critically ill patients. So far COVID-19 in-hospital mortality and modes of death under optimised care conditions have not been systematically studied.

Methods This retrospective observational monocenter cohort study was performed after implementation of a non-restricted, dynamic tertiary care model at the University Medical Center Freiburg, an experienced ARDS and ECMO referral center. All hospitalised patients with PCR-confirmed SARS-CoV-2 infection were included. The primary endpoint was in-hospital mortality, secondary endpoints included major complications and modes of death. A multistate analysis and a Cox regression analysis for competing risk models were performed. Modes of death were determined by two independent reviewers.

Results Between February 25, and May 8, 213 patients were included in the analysis. The median age was 65 years, 129 patients (61%) were male. 70 patients (33%) were admitted to the intensive care unit (ICU), of which 57 patients (81%) received mechanical ventilation and 23 patients (33%) extracorporeal membrane-oxygenation (ECMO) support. According to the multistate model the probability to die within 90 days after COVID-19 onset was 24% in the whole cohort. If the levels of care at time of study entry were accounted for, the probabilities to die were 16% if the patient was initially on a regular ward, 47% if in the ICU and 57% if mechanical ventilation was required at study entry. Age ≥65 years and male sex were predictors for in-hospital death. Predominant complications – as judged by two independent reviewers – determining modes of death were multi-organ failure, septic shock and thromboembolic and hemorrhagic complications.

Conclusion In a dynamic care model COVID-19-related in-hospital mortality remained substantial. In the absence of potent antiviral agents, strategies to alleviate or prevent the identified complications should be investigated. In this context, multistate analyses enable comparison of models-of-care and treatment strategies and allow estimation and allocation of health care resources.

Registration German Clinical Trials Register (identifier DRKS00021775), retrospectively registered June 10, 2020.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

DRKS00021775

Funding Statement

MVC was funded by the EQUIP programme of the Faculty of Medicine, University of Freiburg.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study and data collection were approved by the Institutional Review Board of the University Medical Center Freiburg (348/20) and was registered in the German Clinical Trials Register (identifier DRKS00021775). We followed the ethical standards set by the Helsinki Declaration of 1964, as revised in 2013, and the research guidelines of the University of Freiburg. The Institutional Review Board of the University Medical Center Freiburg considered the collection of routine data as evaluation of service and waived the need for written informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • with linked authorship to members in the Acknowledgements: COVID UKF Study Group: Gabriele Peyerl-Hoffmann, Stephan Horn, Daniel Hornuss, Katharina Laubner, Dominik Bettinger, Christoph Jäger, Eric Peter Prager, Viviane Zotzmann, Dawid L. Staudacher, Cornelius Waller, Hans Fuchs, Sebastian Fähndrich, Marcus Panning, Hans-Jörg Busch, Monika Engelhardt, Hartmut Bürkle, Michael Berchtold-Herz, Thorsten Hammer, Felix Hans, Hartmut Hengel, Peter Hasselblatt, Wolfgang Kühn, Daniel Duerschmied, Robert Thimme, Christoph Bode, Hajo Grundmann, Philipp Henneke

Data Availability

The dataset analysed in this study is available from the corresponding author on reasonable request.

  • List of abbreviations

    COVID-19
    Coronavirus disease 2019
    ECMO
    Extracorporeal membrane-oxygenation
    ICU
    Intensive care unit
    BMI
    Body mass index BMI
    ID
    Infectious Diseases
    MV
    Mechanical ventilation
    SAPS2-score
    Simplified acute physiology score 2
    HR
    Hazard ratio
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted July 24, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany
    Siegbert Rieg, Maja von Cube, Johannes Kalbhenn, Stefan Utzolino, Katharina Pernice, Lena Bechet, Johanna Baur, Corinna N. Lang, Dirk Wagner, Martin Wolkewitz, Winfried V. Kern, Paul Biever
    medRxiv 2020.07.22.20160127; doi: https://doi.org/10.1101/2020.07.22.20160127
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany
    Siegbert Rieg, Maja von Cube, Johannes Kalbhenn, Stefan Utzolino, Katharina Pernice, Lena Bechet, Johanna Baur, Corinna N. Lang, Dirk Wagner, Martin Wolkewitz, Winfried V. Kern, Paul Biever
    medRxiv 2020.07.22.20160127; doi: https://doi.org/10.1101/2020.07.22.20160127

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (76)
    • Allergy and Immunology (196)
    • Anesthesia (54)
    • Cardiovascular Medicine (489)
    • Dentistry and Oral Medicine (89)
    • Dermatology (56)
    • Emergency Medicine (168)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
    • Epidemiology (5681)
    • Forensic Medicine (3)
    • Gastroenterology (215)
    • Genetic and Genomic Medicine (866)
    • Geriatric Medicine (88)
    • Health Economics (231)
    • Health Informatics (762)
    • Health Policy (390)
    • Health Systems and Quality Improvement (252)
    • Hematology (105)
    • HIV/AIDS (182)
    • Infectious Diseases (except HIV/AIDS) (6474)
    • Intensive Care and Critical Care Medicine (390)
    • Medical Education (117)
    • Medical Ethics (28)
    • Nephrology (92)
    • Neurology (847)
    • Nursing (44)
    • Nutrition (141)
    • Obstetrics and Gynecology (163)
    • Occupational and Environmental Health (260)
    • Oncology (514)
    • Ophthalmology (163)
    • Orthopedics (44)
    • Otolaryngology (106)
    • Pain Medicine (48)
    • Palliative Medicine (21)
    • Pathology (149)
    • Pediatrics (250)
    • Pharmacology and Therapeutics (146)
    • Primary Care Research (114)
    • Psychiatry and Clinical Psychology (966)
    • Public and Global Health (2228)
    • Radiology and Imaging (377)
    • Rehabilitation Medicine and Physical Therapy (174)
    • Respiratory Medicine (312)
    • Rheumatology (109)
    • Sexual and Reproductive Health (80)
    • Sports Medicine (82)
    • Surgery (118)
    • Toxicology (25)
    • Transplantation (34)
    • Urology (42)